ergotamine has been researched along with Schizophrenia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bjørn-Yoshimoto, WE; Che, T; Cheng, J; Ding, K; Gloriam, DE; Han, GW; Hanson, MA; Harpsøe, K; Huang, XP; Jensen, AA; Katritch, V; Lansu, K; Liu, ZJ; McCorvy, JD; Nikolajsen, LF; Peng, Y; Popov, P; Pu, M; Qu, L; Roth, BL; Shen, L; Stevens, RC; Wacker, D; Wu, Y; Yuan, S; Zhao, S | 1 |
1 other study(ies) available for ergotamine and Schizophrenia
Article | Year |
---|---|
5-HT
Topics: Ergotamine; HEK293 Cells; Humans; Obesity; Protein Domains; Receptor, Serotonin, 5-HT2C; Ritanserin; Schizophrenia; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Structure-Activity Relationship; Substance-Related Disorders | 2018 |